期刊
EUROPEAN JOURNAL OF CANCER
卷 81, 期 -, 页码 135-137出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.ejca.2017.05.017
关键词
Emergent adverse event; Immune-related adverse event; Eosinophilia; Anti-programmed death 1; Anti-programmed death ligand 1